If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiske Regulatory News (FKE)

Share Price Information for Fiske (FKE)

Share Price is delayed by 15 minutes
Get Live Data
60.00    0.00 (0.00%)
Bid:
55.00
Ask:
65.00
Spread: 10.00 (18.182%)
Market Cap: £7.10m
FKE Live PriceLast checked at - London Stock Exchange

Intraday Fiske Share Chart

Issue of Equity

4 Sep 2019 15:40

RNS Number : 2503L
Fiske PLC
04 September 2019
 

 

 

4 September 2019

 

Fiske Plc

 

Issue of Equity

 

Fiske plc ('Fiske' or 'the Company') today announces that further to the acquisition of Fieldings Investment Management Ltd ("Fieldings") announced on 27 July 2017, the second deferred consideration payment due to the vendors of Fieldings will be £238,094 (the "Second Deferred Consideration"). In accordance with the agreement, 20 per cent. of the Second Deferred Consideration is payable in ordinary shares of 25p each in the Company ("Ordinary Shares") issued at the average closing price of the 15 business days prior to allotment. The Company has therefore issued 76,193 Ordinary Shares at a price of 62.5p each.

 

Application has been made for these new Ordinary Shares to be admitted to trading on AIM with admission expected to take place on, or around, 10 September 2019 ("Admission").

 

Following Admission, the Company's enlarged share capital will comprise 11,693,790 Ordinary Shares. No shares are held in Treasury. Therefore, the total number of Ordinary Shares with voting rights is 11,693,790. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

4,773 Ordinary Shares will be issued to Tony Pattison, Director of the Company and previously a shareholder of Fieldings. Following the issue of these new shares, Mr Pattison will hold 290,831 Ordinary Shares representing 2.49 per cent. of the Company's total voting rights. The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Pursuant to the details of the acquisition announced on 27 July 2017, the third and final deferred consideration payment will be made next year.

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

For further information please contact:

 

Samantha Harrison, Harrison Clarke - Grant Thornton UK LLP (Nominated Adviser)

(tel: 020 7383 5100)

 

Gerard Luchini, Fiske Plc - Compliance Officer

(tel: 020 7448 4700)

 

 

 

1 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

 

Tony Pattison

2

Reason for the notification 

 

a)

Position/status 

 

Director

b)

Initial notification /Amendment 

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name 

 

Fiske Plc

b)

LEI

 

213800Z5PKJOV7GWXE43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument 

Identification code 

Ordinary shares of 25 pence each

 

ISIN GB00BJRHYM66

 

FISK

b)

Nature of the transaction 

 

Issue of shares

c)

Price(s) and volume(s)

 

Price(s)

 

62.5p

 

Volume(s)

 

4,773

 

d)

 

Aggregated information 

 

N/A (single transaction)

 

 

e)

Date of the transaction 

 

4 September 2019

f)

Place of the transaction 

 

Outside of trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOELLFVSATISIIA
Date   Source Headline
26th Feb 20267:00 amRNSInterim results
25th Nov 20252:39 pmRNSDirector Dealing
13th Nov 20252:47 pmRNSResult of AGM
24th Oct 20255:30 pmRNSDirector Dealing - Replacement
24th Oct 20252:09 pmRNSDirector Dealing
20th Oct 20257:00 amRNSFinal Results, Annual Report and Notice of AGM
24th Sep 20257:01 amRNSTrading Update - Year to 30 June 2025
24th Sep 20257:00 amRNSAnnouncement of VREQ
18th Jul 20254:29 pmRNSHolding(s) in Company
28th Feb 20257:00 amRNSInterim results
12th Dec 20242:04 pmRNSResult of AGM
18th Nov 20247:00 amRNSFinal Results, Annual Report and Notice of AGM
15th Apr 20244:27 pmRNSDirector Dealing
6th Mar 202411:51 amRNSDirector Dealing
22nd Feb 20241:21 pmRNSDirector Dealing
19th Feb 20244:38 pmRNSDirector Dealing
16th Feb 20242:47 pmRNSDirector Dealing
16th Feb 20247:00 amRNSInterim results
8th Dec 20234:56 pmRNSDirector Dealing
28th Nov 20233:38 pmRNSDirector Dealing
23rd Nov 202312:52 pmRNSResult of AGM and Confirmation of Board Changes
30th Oct 20233:42 pmRNSDirector Dealing
24th Oct 20237:00 amRNSFinal Results, Annual Report and Notice of AGM
22nd Aug 20231:19 pmRNSDirector dealing
6th Jul 20237:00 amRNSDirector Dealing
31st May 20233:27 pmRNSDirector Dealing
4th Apr 202312:38 pmRNSDirector Dealing
3rd Apr 202310:55 amRNSDirector Dealing
3rd Apr 20237:00 amRNSAcquisition of Client Book
2nd Mar 20237:00 amRNSInterim results
29th Nov 20221:58 pmRNSDirector Dealings
24th Nov 20225:31 pmRNSResult of AGM
20th Oct 20227:00 amRNSFinal Results, Annual Report and Notice of AGM
18th Aug 20229:30 amRNSHolding(s) in Company
17th Jun 20224:13 pmRNSDirector Dealing
1st Mar 20227:00 amRNSHalf-year Report
17th Dec 20214:47 pmRNSDirector Dealing
10th Dec 20217:00 amRNSChange to Accounting Year End
30th Nov 20217:00 amRNSChange of Registered Office
25th Oct 202110:56 amRNSResult of AGM
30th Sep 202111:23 amRNSTotal Voting Rights
29th Sep 20215:29 pmRNSDirector Dealing
17th Sep 20211:08 pmRNSDirector Shareholding & Director Dealing
17th Sep 20219:58 amRNSExercise of Share Options and Issue of Equity
14th Sep 20219:44 amRNSFinal Results, Annual Report and Notice of AGM
5th Jul 202112:56 pmRNSHolding(s) in Company
28th May 20214:21 pmRNSDirector Dealings and Director Shareholding Update
20th Apr 20217:00 amRNSDirector Shareholding Disclosure
19th Feb 20217:00 amRNSInterim Results
8th Feb 20215:28 pmRNSForm 8.3 - Marston's PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.